**Trader consensus strongly favors an 85–90 cumulative flu hospitalization rate per 100,000 population for Week 23, 2026 (94.5% implied probability), reflecting the 2025–2026 season’s trajectory and current low transmission.** CDC FluSurv-NET data show weekly rates fell sharply after the winter peak (around 12–13 per 100,000 in late December/early January) to just 0.2 per 100,000 by Week 18 in mid-May, with cumulative rates reaching 86.3 per 100,000. National laboratory-confirmed admissions have since remained minimal, and ensemble forecasts project only 320–2,000 new admissions for the week ending June 13. Seasonal influenza activity is classified as low, consistent with historical patterns of near-zero summer transmission outside the typical October–May window. This positioning rests on verified surveillance trends rather than models alone. A realistic challenge would require an unprecedented off-season surge—such as a novel strain causing sustained community transmission—that pushes cumulative totals outside the 85–90 band before final reporting. No such signals appear in current CDC or clinical laboratory data.
Resumen experimental generado por IA con datos de Polymarket. Esto no es asesoramiento de trading y no influye en cómo se resuelve este mercado. · ActualizadoFlu Hospitalization Rate Week 23, 2026?
Flu Hospitalization Rate Week 23, 2026?
85–90 94.4%
90–95 3.8%
<80 <1%
95–100 <1%
NUEVO
NUEVO
19 jun 2026
<80
1%
80–85
<1%
85–90
94%
90–95
4%
95–100
1%
100+
<1%
85–90 94.4%
90–95 3.8%
<80 <1%
95–100 <1%
NUEVO
NUEVO
19 jun 2026
<80
$402 Vol.
1%
80–85
$397 Vol.
<1%
85–90
$3,036 Vol.
94%
90–95
$143 Vol.
4%
95–100
$245 Vol.
1%
100+
$455 Vol.
<1%
This market will resolve according to the cumulative influenza-associated hospitalization rate per 100,000 population for the United States, as reported for the specified week.
If the recorded data falls exactly between two brackets, this market will resolve to the higher bracket.
The resolution source for this market will be CDC FluView / FluSurv-NET (see: https://www.cdc.gov/fluview/index.html). If the FluSurv-NET hospitalization rate for the specified week is not released by 11:59 PM ET on the tenth calendar day following the date of the prior FluView weekly report release, this market will resolve to the lowest bracket.
Note: Only the CDC FluSurv-NET cumulative hospitalization rate per 100,000 population for the specified week will qualify, regardless of estimates, projections, state-level reports, or other influenza surveillance metrics published by the CDC or other sources.**Trader consensus strongly favors an 85–90 cumulative flu hospitalization rate per 100,000 population for Week 23, 2026 (94.5% implied probability), reflecting the 2025–2026 season’s trajectory and current low transmission.**
CDC FluSurv-NET data show weekly rates fell sharply after the winter peak (around 12–13 per 100,000 in late December/early January) to just 0.2 per 100,000 by Week 18 in mid-May, with cumulative rates reaching 86.3 per 100,000. National laboratory-confirmed admissions have since remained minimal, and ensemble forecasts project only 320–2,000 new admissions for the week ending June 13. Seasonal influenza activity is classified as low, consistent with historical patterns of near-zero summer transmission outside the typical October–May window.
This positioning rests on verified surveillance trends rather than models alone. A realistic challenge would require an unprecedented off-season surge—such as a novel strain causing sustained community transmission—that pushes cumulative totals outside the 85–90 band before final reporting. No such signals appear in current CDC or clinical laboratory data.
This market will resolve according to the cumulative influenza-associated hospitalization rate per 100,000 population for the United States, as reported for the specified week.
If the recorded data falls exactly between two brackets, this market will resolve to the higher bracket.
The resolution source for this market will be CDC FluView / FluSurv-NET (see: https://www.cdc.gov/fluview/index.html). If the FluSurv-NET hospitalization rate for the specified week is not released by 11:59 PM ET on the tenth calendar day following the date of the prior FluView weekly report release, this market will resolve to the lowest bracket.
Note: Only the CDC FluSurv-NET cumulative hospitalization rate per 100,000 population for the specified week will qualify, regardless of estimates, projections, state-level reports, or other influenza surveillance metrics published by the CDC or other sources.
If the recorded data falls exactly between two brackets, this market will resolve to the higher bracket.
The resolution source for this market will be CDC FluView / FluSurv-NET (see: https://www.cdc.gov/fluview/index.html). If the FluSurv-NET hospitalization rate for the specified week is not released by 11:59 PM ET on the tenth calendar day following the date of the prior FluView weekly report release, this market will resolve to the lowest bracket.
Note: Only the CDC FluSurv-NET cumulative hospitalization rate per 100,000 population for the specified week will qualify, regardless of estimates, projections, state-level reports, or other influenza surveillance metrics published by the CDC or other sources.
Mercado abierto: Jun 12, 2026, 7:22 PM ET
Volumen
$4,679Fecha de finalización
19 jun 2026Mercado abierto
Jun 12, 2026, 7:22 PM ETResolver
0x69c47De9D...This market will resolve according to the cumulative influenza-associated hospitalization rate per 100,000 population for the United States, as reported for the specified week.
If the recorded data falls exactly between two brackets, this market will resolve to the higher bracket.
The resolution source for this market will be CDC FluView / FluSurv-NET (see: https://www.cdc.gov/fluview/index.html). If the FluSurv-NET hospitalization rate for the specified week is not released by 11:59 PM ET on the tenth calendar day following the date of the prior FluView weekly report release, this market will resolve to the lowest bracket.
Note: Only the CDC FluSurv-NET cumulative hospitalization rate per 100,000 population for the specified week will qualify, regardless of estimates, projections, state-level reports, or other influenza surveillance metrics published by the CDC or other sources.**Trader consensus strongly favors an 85–90 cumulative flu hospitalization rate per 100,000 population for Week 23, 2026 (94.5% implied probability), reflecting the 2025–2026 season’s trajectory and current low transmission.**
CDC FluSurv-NET data show weekly rates fell sharply after the winter peak (around 12–13 per 100,000 in late December/early January) to just 0.2 per 100,000 by Week 18 in mid-May, with cumulative rates reaching 86.3 per 100,000. National laboratory-confirmed admissions have since remained minimal, and ensemble forecasts project only 320–2,000 new admissions for the week ending June 13. Seasonal influenza activity is classified as low, consistent with historical patterns of near-zero summer transmission outside the typical October–May window.
This positioning rests on verified surveillance trends rather than models alone. A realistic challenge would require an unprecedented off-season surge—such as a novel strain causing sustained community transmission—that pushes cumulative totals outside the 85–90 band before final reporting. No such signals appear in current CDC or clinical laboratory data.
This market will resolve according to the cumulative influenza-associated hospitalization rate per 100,000 population for the United States, as reported for the specified week.
If the recorded data falls exactly between two brackets, this market will resolve to the higher bracket.
The resolution source for this market will be CDC FluView / FluSurv-NET (see: https://www.cdc.gov/fluview/index.html). If the FluSurv-NET hospitalization rate for the specified week is not released by 11:59 PM ET on the tenth calendar day following the date of the prior FluView weekly report release, this market will resolve to the lowest bracket.
Note: Only the CDC FluSurv-NET cumulative hospitalization rate per 100,000 population for the specified week will qualify, regardless of estimates, projections, state-level reports, or other influenza surveillance metrics published by the CDC or other sources.
If the recorded data falls exactly between two brackets, this market will resolve to the higher bracket.
The resolution source for this market will be CDC FluView / FluSurv-NET (see: https://www.cdc.gov/fluview/index.html). If the FluSurv-NET hospitalization rate for the specified week is not released by 11:59 PM ET on the tenth calendar day following the date of the prior FluView weekly report release, this market will resolve to the lowest bracket.
Note: Only the CDC FluSurv-NET cumulative hospitalization rate per 100,000 population for the specified week will qualify, regardless of estimates, projections, state-level reports, or other influenza surveillance metrics published by the CDC or other sources.
Volumen
$4,679Fecha de finalización
19 jun 2026Mercado abierto
Jun 12, 2026, 7:22 PM ETResolver
0x69c47De9D...**Trader consensus strongly favors an 85–90 cumulative flu hospitalization rate per 100,000 population for Week 23, 2026 (94.5% implied probability), reflecting the 2025–2026 season’s trajectory and current low transmission.** CDC FluSurv-NET data show weekly rates fell sharply after the winter peak (around 12–13 per 100,000 in late December/early January) to just 0.2 per 100,000 by Week 18 in mid-May, with cumulative rates reaching 86.3 per 100,000. National laboratory-confirmed admissions have since remained minimal, and ensemble forecasts project only 320–2,000 new admissions for the week ending June 13. Seasonal influenza activity is classified as low, consistent with historical patterns of near-zero summer transmission outside the typical October–May window. This positioning rests on verified surveillance trends rather than models alone. A realistic challenge would require an unprecedented off-season surge—such as a novel strain causing sustained community transmission—that pushes cumulative totals outside the 85–90 band before final reporting. No such signals appear in current CDC or clinical laboratory data.
Resumen experimental generado por IA con datos de Polymarket. Esto no es asesoramiento de trading y no influye en cómo se resuelve este mercado. · Actualizado
Cuidado con los enlaces externos.
Cuidado con los enlaces externos.
Preguntas frecuentes